|
|
|
Mornidine advertisement, 1959. Canadian Medical Association Journal, Vol. 81, No. 1, p. 59. Now she can cook breakfast again ... when you prescribe new MORNIDINE (brand of pipamazine) A new drug with specific effectiveness in nausea and vomiting of pregnancy, Mornidine eliminates the ordeal of morning sickness. With its selective action on the vomiting center, or the medullary chemoreceptor "trigger zone," Mornidine possesses the advantages of the phenothiazine drugs without unwanted tranquilizing activity. Doses of 5 to 10 mg., repeated at intervals of six to eight hours, provide excellent relief all day. In patients who are unable to retain oral medication when first seen, Mornidine may be administered intramuscularly in doses of 5 mg. (1 cc.). Mornidine is supplied as tablets of 5 mg. and as ampuls of 5 mg. (1 cc.). G. D. Searle & Co. of Canada Ltd. 247 Queen St., E., Brampton, Ont. Pipamazine (Mornidine) was removed from the U.S. market in July 1969, following reports of liver toxicity. |